Tracy L. Kirkham
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tracy L. Kirkham has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Paul A. Demers
Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
2 shared publications - Anne-Marie Nicol
Faculty of Health Sciences, Simon Fraser University, Burnaby, BC V5A 1S6, Canada
1 shared publication - Brian Grunau
University of British Columbia
1 shared publication - David M. Goldfarb
14 British Columbia Children’s Hospital, Vancouver, Canada
1 shared publication - Iryna Kayda
Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada
1 shared publication - Jeffrey M. Copp
British Columbia Emergency Health Services, British Columbia, Canada
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by Microbiology Society in Access Microbiology
- Vol. 7 (1) , 000791.v3
Immunogenicity of bivalent versus monovalent mRNA booster vaccination among adult paramedics in Canada who had received three prior mRNA wild-type doses
Introduction. Comparative immunogenicity from different mRNA booster vaccines (directed at WT, BA.1 or BA.4/5 antigens) remains unclear. Methods. We included blood samples from adult paramedics who received three mRNA WT-directed vaccines plus a fourth dose of the following: (1) WT monovalent, (2) Moderna BA.1-WT bivalent or (3) Pfizer BA.4/5 WT bivalent vaccine. The primary outcome was angiotensin-converting enzyme 2 (ACE2) inhibition to BA.4/5 antigen. We used optimal pair matching (using age, sex-at-birth, preceding SARS-CoV-2 infection and fourth vaccine-to-blood collection interval) to create balanced groups to individually compare each vaccine type to each other vaccine (overall, within subgroups defined by SARS-CoV-2 infection and after combining BA.1 and BA.4/5 cases). We compared outcomes with the Wilcoxon matched-pairs signed rank test. Results. Overall, 158 paramedics (mean age 45 years) were included. ACE2 inhibition was higher for BA.1 compared to WT (P=0.002); however, no difference was detected between BA.4/5 vs. WT or BA.1 vs. BA.4/5. Among cases with preceding SARS-CoV-2, there were no detected between-group differences. Among cases without preceding SARS-CoV-2, the only detected difference was BA.1>WT (P=0.003). BA.1 and BA.4/5 cases combined had higher ACE2 inhibition than WT (P=0.003). Conclusion. Omicron-directed vaccines appear to improve Omicron-specific immunogenicity; however, this appears limited to SARS-CoV-2-naive individuals.
- 1 January 2025
- Published by Microbiology Society in Access Microbiology
- Vol. 7 (1) , 000791.v3
Open AccessImmunogenicity of bivalent versus monovalent mRNA booster vaccination among adult paramedics in Canada who had received three prior mRNA wild-type doses
Introduction. Comparative immunogenicity from different mRNA booster vaccines (directed at WT, BA.1 or BA.4/5 antigens) remains unclear. Methods. We included blood samples from adult paramedics who received three mRNA WT-directed vaccines plus a fourth dose of the following: (1) WT monovalent, (2) Moderna BA.1-WT bivalent or (3) Pfizer BA.4/5 WT bivalent vaccine. The primary outcome was angiotensin-converting enzyme 2 (ACE2) inhibition to BA.4/5 antigen. We used optimal pair matching (using age, sex-at-birth, preceding SARS-CoV-2 infection and fourth vaccine-to-blood collection interval) to create balanced groups to individually compare each vaccine type to each other vaccine (overall, within subgroups defined by SARS-CoV-2 infection and after combining BA.1 and BA.4/5 cases). We compared outcomes with the Wilcoxon matched-pairs signed rank test. Results. Overall, 158 paramedics (mean age 45 years) were included. ACE2 inhibition was higher for BA.1 compared to WT (P=0.002); however, no difference was detected between BA.4/5 vs. WT or BA.1 vs. BA.4/5. Among cases with preceding SARS-CoV-2, there were no detected between-group differences. Among cases without preceding SARS-CoV-2, the only detected difference was BA.1>WT (P=0.003). BA.1 and BA.4/5 cases combined had higher ACE2 inhibition than WT (P=0.003). Conclusion. Omicron-directed vaccines appear to improve Omicron-specific immunogenicity; however, this appears limited to SARS-CoV-2-naive individuals.
- Open Access
- 28 December 2024
- Published by MDPI AG in Atmosphere
- Vol. 16 (1) , 21
Characterizing Radon Among Public Buildings and Small/Medium-Sized Businesses in a Canadian Province
Radon is a naturally occurring radioactive gas that causes lung cancer. It has been measured extensively in homes and mines but research in other workplaces has been limited. The present study examined 453 workplaces in Ontario, Canada, to characterize radon levels. Radon monitors (n = 687) were placed in occupied ground floor and basement workplace locations for a minimum of three months. The radon measurements ranged from 3, with a median of 26 Bq/m3, arithmetic mean of 40.2 Bq/m3, and geometric mean of 26.9 Bq/m3. Using the Health Canada and Ontario labor guideline of 200 Bq/m3, 2.5% of participating workplaces had at least one measurement above this level; 7.2% were above the World Health Organization guideline. Workplaces were also asked to fill out questionnaires to identify possible determinants of exposure. Radon levels varied significantly based on municipality and background radon zone, highlighting the importance of geography in influencing radon levels. Radon levels also varied significantly based on window-opening behavior, business access type, the presence of an elevator, air conditioning, additions to the building, and cracks and/or gaps in the foundation/wall and around drains, indicating building characteristics with some influence on air circulation may impact overall radon levels.
- 28 December 2024
- Published by MDPI AG in Atmosphere
- Vol. 16 (1) , 21
Open AccessCharacterizing Radon Among Public Buildings and Small/Medium-Sized Businesses in a Canadian Province
Radon is a naturally occurring radioactive gas that causes lung cancer. It has been measured extensively in homes and mines but research in other workplaces has been limited. The present study examined 453 workplaces in Ontario, Canada, to characterize radon levels. Radon monitors (n = 687) were placed in occupied ground floor and basement workplace locations for a minimum of three months. The radon measurements ranged from 3, with a median of 26 Bq/m3, arithmetic mean of 40.2 Bq/m3, and geometric mean of 26.9 Bq/m3. Using the Health Canada and Ontario labor guideline of 200 Bq/m3, 2.5% of participating workplaces had at least one measurement above this level; 7.2% were above the World Health Organization guideline. Workplaces were also asked to fill out questionnaires to identify possible determinants of exposure. Radon levels varied significantly based on municipality and background radon zone, highlighting the importance of geography in influencing radon levels. Radon levels also varied significantly based on window-opening behavior, business access type, the presence of an elevator, air conditioning, additions to the building, and cracks and/or gaps in the foundation/wall and around drains, indicating building characteristics with some influence on air circulation may impact overall radon levels.